CIK 0000887359 · Large accelerated filer
Vericel Corp
Sign in to watch- Ticker
- VCEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- MI
- Entity type
- operating
- EIN
- 943096597
- Phone
- 6175885555
- Business address
- 25 BLUE SKY DRIVE, BURLINGTON, MA, 01803
- Former names
- AASTROM BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,787,802
- in 7 filings, $5.8M under 10b5-1 plans
Net −$5,787,802. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Mara Joseph Anthony Jr −$4.1M Chief Financial Officer sold 82% of stake
- Flynn Sean C. −$779K Chief Legal Officer sold 88% of stake
- MCLAUGHLIN KEVIN F −$413K Director sold 28% of stake
- ZERBE ROBERT L MD −$386K Director sold 19% of stake
- SIEGAL JONATHAN −$79K Principal Accounting Officer sold 54% of stake
Reading 65 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-04-10 | Colangelo Dominick President and CEO | Sale 10b5-1 | −24,850 | $41.89 | $1.0M | 260,354 |
| 2025-04-10 | Colangelo Dominick President and CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | +24,850 | 0 | ||
| 2025-04-09 | Colangelo Dominick President and CEO | Option exercise 10b5-1 | +24,850 | $2.75 | $68K | 285,204 |
| 2025-04-09 | Colangelo Dominick President and CEO | Sale 10b5-1 | −24,850 | $41.11 | $1.0M | 260,354 |
| 2025-04-09 | Colangelo Dominick President and CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | +24,850 | 24,850 | ||
| 2025-03-13 | Colangelo Dominick President and CEO | Option exercise 10b5-1 | +26,592 | $1.95 | $52K | 286,589 |
| 2025-03-13 | Colangelo Dominick President and CEO | Sale 10b5-1 | −26,592 | $45.78 | $1.2M | 259,997 |
| 2025-03-13 | Colangelo Dominick President and CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | +26,592 | 0 | ||
| 2025-03-12 | Colangelo Dominick President and CEO | Option exercise 10b5-1 | +26,591 | $1.95 | $52K | 286,588 |
| 2025-03-12 | Colangelo Dominick President and CEO | Sale 10b5-1 | −26,591 | $46.31 | $1.2M | 259,997 |
| 2025-03-12 | Colangelo Dominick President and CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | +26,591 | 26,592 | ||
| 2025-03-03 | Halpin Michael Chief Operating Officer | Option exercise 10b5-1 | +10,000 | $16.66 | $167K | 25,359 |
| 2025-03-03 | Halpin Michael Chief Operating Officer | Sale 10b5-1 | −10,000 | $49.52 | $495K | 15,539 |
| 2025-03-03 | Halpin Michael Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | +10,000 | 66,250 | ||
| 2025-03-03 | Hagen Heidi Director | Option exercise 10b5-1 | +9,000 | $3.74 | $34K | 37,650 |
| 2025-03-03 | Hagen Heidi Director | Sale 10b5-1 | −9,000 | $49.53 | $446K | 28,650 |
| 2025-03-03 | Hagen Heidi Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | +9,000 | 0 | ||
| 2025-03-03 | Mara Joseph Anthony Jr Chief Financial Officer | Sale 10b5-1 | −9,000 | $49.53 | $446K | 13,967 |
| 2025-03-03 | Hopper Jonathan Mark Chief Medical Officer | Option exercise 10b5-1 | +10,000 | $18.00 | $180K | 76,101 |
| 2025-03-03 | Hopper Jonathan Mark Chief Medical Officer | Sale 10b5-1 | −10,000 | $49.53 | $495K | 66,101 |
Page 15 of 75 · 1,497 trades